元道通信(301139.SZ):因涉嫌年報等信息披露文件財務數據存在虛假記載等違法行爲 收到證監會立案告知書
格隆匯7月11日丨元道通信(301139.SZ)公佈,公司(以下簡稱“公司”)於2025年7月11日收到中國證券監督管理委員會下發的《立案告知書》(編號:證監立案字03720253016號),因公司涉嫌年報等信息披露文件財務數據存在虛假記載等違法行爲,根據《中華人民共和國證券法》《中華人民共和國行政處罰法》等法律法規,中國證監會決定對公司立案。
若後續經中國證監會行政處罰認定的事實,觸及《深圳證券交易所創業板股票上市規則(2025年修訂)》規定的重大違法強制退市情形,公司股票將被實施重大違法強制退市。敬請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.